Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial
Jackson, Graham H, Davies, Faith E, Pawlyn, Charlotte, Cairns, David A, Striha, Alina, Collett, Corinne, Hockaday, Anna, Jones, John R, Kishore, Bhuvan, Garg, Mamta, Williams, Cathy D, Karunanithi, KaLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(18)30687-9
Date:
December, 2018
File:
PDF, 2.58 MB
english, 2018